Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance  Anette.

Slides:



Advertisements
Similar presentations
Pregnancy rates after embryo transfer depend on the provider at embryo transfer22 Rhonda M Hearns-Stokes, M.D., Bradley T Miller, M.D., Lynette Scott,
Advertisements

Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice Michelle Nisolle, M.D., Ph.D., Françoise Casanas-Roux, B.S.,
Carlos Morán, M. D. , Eric Knochenhauer, M. D. , Larry R Boots, Ph. D
Huang Jin, Master, Liu Ping, M. D. , Qiao Jie, M. D
Evaluation and Management of Amenorrhea
Male contraception Fertility and Sterility
Follicular and endocrine response to anastrozole versus clomiphene citrate administered in follicular phase to normoovulatory women: a randomized comparison 
Fernando Zegers-Hochschild, M.D.  Fertility and Sterility 
Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis  Ioannis P. Kosmas, M.D.,
Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials  Ana Cobo, Ph.D., César Diaz, M.D. 
A randomized trial of the effect of testosterone and estrogen on verbal fluency, verbal memory, and spatial ability in healthy postmenopausal women  Ljiljana.
Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy  Peter Conner, M.D., Gunilla Svane, M.D., Ph.D.,
A randomized trial comparing monopolar electrodes using glycine 1
Randomized comparison of the influence of dietary management and/or physical exercise on ovarian function and metabolic parameters in overweight women.
Effects of testosterone and estrogen treatment on lipolysis signaling pathways in subcutaneous adipose tissue of postmenopausal women  Hong Zang, M.D.,
Temporal trends in clomiphene citrate use: a population-based study
Angela C Meyer, M. D. , John C Papadimitriou, M. D. , Ph. D
Live birth of twins derived from zona-free oocytes
How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization  Robert L. Klitzman, M.D.  Fertility.
Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian postmenopausal women  Raymond W Ke,
Predictive factors of health-related quality of life in patients with polycystic ovary syndrome: a structural equation modeling approach  Fatemeh Bazarganipour,
Role of androgen-mediated enhancement of erythropoiesis in the increased body iron stores of patients with polycystic ovary syndrome  Héctor F. Escobar-Morreale,
Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian.
Changes in circulating levels and ratios of angiopoietins during pregnancy but not during the menstrual cycle and controlled ovarian stimulation  Amanda.
Reply of the Authors Fertility and Sterility
Robert F. Casper, M.D.  Fertility and Sterility 
Mieke Carine Wim Eeckhaut, Ph.D.  Fertility and Sterility 
Drug Infusors in Palliative Medicine
Serum luteinizing hormone levels are markedly increased and significantly correlated with Δ4-androstenedione levels in lean women with polycystic ovary.
Mark D Hornstein, M. D. , Owen K Davis, M. D. , Joe B Massey, M. D
David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D. 
From partner's desk to iPad
Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials  Philip Darney, M.D., Ashlesha Patel,
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage,
Relationship between sleep and secretion of gonadotropin and ovarian hormones in women with normal cycles  Sandrine Touzet, M.D., Muriel Rabilloud, M.D.,
Kurt T Barnhart, M. D. , M. S. C. E. , Thomas Bader, M. D
David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F
Ri-Cheng Chian, Ph.D., Peter S. Uzelac, M.D., Geeta Nargund, M.D. 
Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular.
Regulation of assisted reproductive technologies in the United States
Roberto Ensenat-Waser, Ph. D. , Antonio Pellicer, M. D. , Ph. D
Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women  Hong Zang, M.D., Kjell Carlström,
Hassan N Sallam, M.D., Ph.D., F.R.C.O.G., Sameh S Sadek, M.D. 
Decreased levels of interleukin-18 in peritoneal fluid but not in serum of patients with endometriosis  Xinmei Zhang, M.D., Jun Lin, M.D., Yuli Qian,
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D. 
Lisa F. Schneider, M. D. , Sara E. Monaco, M. D. , Michelle P
János Urbancsek, M. D. , Ph. D. , Erik E. Hauzman, M. D. , Ana R
Thilo Schill, M. D. , Monika Bals-Pratsch, M. D. , Wolfgang Küpker, M
Interleukin 1β, interleukin-6, and tumor necrosis factor-α in endometriotic tissue and in endometrium  Agneta Bergqvist, M.D., Ph.D., Christine Bruse,
Insulin growth factors may be implicated in human sperm capacitation
Current evaluation of amenorrhea
Inappropriate gonadotropin secretion in polycystic ovary syndrome
Ronald M. Yang, M. D. , Richard A. Fefferman, M. D. , Charles E
Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study  Xiaobin Wang, M.D., Changzhong Chen, M.D., Lihua.
Aline Ketefian, M. D. , Jianfang Hu, Ph. D. , Alfred A. Bartolucci, Ph
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Hormones, mood, sexuality, and the menopausal transition
Saad Elzanaty, M.D., Ph.D., Johan Malm, M.D., Ph.D. 
Tubal sterilization: focus on the U.S. experience
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles  David.
William R. Boone, Ph. D. , Jeffrey M. Jones, Ph. D. , Sander S
Increased endometrial thickness on the day of human chorionic gonadotropin injection does not adversely affect pregnancy or implantation rates following.
A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility 
Defining the “sweet spot” for administered luteinizing hormone-to-follicle-stimulating hormone gonadotropin ratios during ovarian stimulation to protect.
Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy  Eman A. Elgindy,
P-24 Fertility and Sterility Volume 85, Pages S19-S20 (April 2006)
Increased luteinizing hormone pulse frequency in obese oligomenorrheic girls with no evidence of hyperandrogenism  Richard Y. Yoo, M.D., Asheesh Dewan,
Enrico Carmina, M.D., Rogerio A Lobo, M.D.  Fertility and Sterility 
Presentation transcript:

Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance  Anette Rickenlund, M.D., Kjell Carlström, Ph.D., B.jörn Ekblom, Ph.D., Torkel B. Brismar, M.D., Ph.D., B.o von Schoultz, M.D., Ph.D.,, Angelica Lindén Hirschberg, M.D., Ph.D.  Fertility and Sterility  Volume 79, Issue 4, Pages 947-955 (April 2003) DOI: 10.1016/S0015-0282(02)04850-1

FIGURE 1 Individual values of the T-SHBG ratio in oligoamenorrheic or amenorrheic athletes (OAM), regularly menstruating athletes (RM), and sedentary controls (CTR). The clinical cutoff value of the T-SHBG ratio for hyperandrogenism (0.05) is indicated. Rickenlund. Hyperandrogenicity among female athletes. Fertil Steril 2003. Fertility and Sterility 2003 79, 947-955DOI: (10.1016/S0015-0282(02)04850-1)

FIGURE 2 Individual values of free T, SHBG, A, and LH-FSH ratio in hyperandrogenic, oligoamenorrheic, or amenorrheic athletes (H-OAM); normoandrogenic oligoamenorrheic or amenorrheic athletes (N-OAM); regularly menstruating athletes (RM); and sedentary controls (CTR). Significant differences between H-OAM and the other groups are indicated. *P=.05, **P=.01, ***P=.001. Rickenlund. Hyperandrogenicity among female athletes. Fertil Steril 2003. Fertility and Sterility 2003 79, 947-955DOI: (10.1016/S0015-0282(02)04850-1)